Avalo Therapeutics (AVTX) Current Taxes (2017 - 2019)

Avalo Therapeutics' Current Taxes history runs 3 years deep, the most recent figure standing at $551671.0 for Q4 2019.

• Quarterly Current Taxes fell 72.85% year-over-year to $551671.0 in Q4 2019, while the trailing twelve-month figure through Dec 2019 was $551671.0 (down 72.85% YoY) and the FY2019 annual result came in at $551671.0, down 72.85% from the prior year.
• Current Taxes was $551671.0 for Q4 2019 at Avalo Therapeutics, down from $1.0 million in the prior quarter.
• Across five years, Current Taxes topped out at $3.2 million in Q3 2017 and bottomed at $551671.0 in Q4 2019.
• A 3-year average of $1.9 million and a median of $2.1 million in 2018 frame the typical range for Current Taxes.
• Annual changes were most pronounced in 2018 — Current Taxes dropped 10.04% — and 2019, when it plunged 72.85%.
• Avalo Therapeutics' Current Taxes stood at $2.3 million in 2017, then fell by 10.04% to $2.0 million in 2018, then plunged by 72.85% to $551671.0 in 2019.
• Business Quant data shows AVTX's Current Taxes at $551671.0 in Q4 2019, $1.0 million in Q3 2019, and $1.4 million in Q2 2019.